FR2297858B1 - - Google Patents

Info

Publication number
FR2297858B1
FR2297858B1 FR7601345A FR7601345A FR2297858B1 FR 2297858 B1 FR2297858 B1 FR 2297858B1 FR 7601345 A FR7601345 A FR 7601345A FR 7601345 A FR7601345 A FR 7601345A FR 2297858 B1 FR2297858 B1 FR 2297858B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7601345A
Other languages
French (fr)
Other versions
FR2297858A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of FR2297858A1 publication Critical patent/FR2297858A1/en
Application granted granted Critical
Publication of FR2297858B1 publication Critical patent/FR2297858B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12N9/0024D-Amino acid oxidase (1.4.3.3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/08Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin disubstituted in the 7 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7601345A 1975-01-20 1976-01-20 7A-METHOXYCEPHALOSPORIN DERIVATIVES AND THEIR PREPARATION PROCESS Granted FR2297858A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP850475A JPS5733039B2 (en) 1975-01-20 1975-01-20

Publications (2)

Publication Number Publication Date
FR2297858A1 FR2297858A1 (en) 1976-08-13
FR2297858B1 true FR2297858B1 (en) 1979-05-25

Family

ID=11694935

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7601345A Granted FR2297858A1 (en) 1975-01-20 1976-01-20 7A-METHOXYCEPHALOSPORIN DERIVATIVES AND THEIR PREPARATION PROCESS

Country Status (5)

Country Link
JP (1) JPS5733039B2 (en)
CH (1) CH617939A5 (en)
DE (1) DE2601457A1 (en)
FR (1) FR2297858A1 (en)
GB (1) GB1488103A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3481769D1 (en) * 1984-01-23 1990-05-03 Takeda Chemical Industries Ltd CEPHEM DERIVATIVES AND THEIR PRODUCTION.

Also Published As

Publication number Publication date
GB1488103A (en) 1977-10-05
DE2601457A1 (en) 1976-07-22
FR2297858A1 (en) 1976-08-13
JPS5733039B2 (en) 1982-07-14
JPS5186187A (en) 1976-07-28
CH617939A5 (en) 1980-06-30

Similar Documents

Publication Publication Date Title
JPS5140454Y1 (en)
JPS5199768A (en)
BG21783A1 (en)
BG22116A1 (en)
BG22264A1 (en)
BG22460A1 (en)
BG23454A1 (en)
BG23472A1 (en)
CH325575A4 (en)
CH575340A5 (en)
CH576760A5 (en)
CH580337A5 (en)
CH582928A5 (en)
CH583052A5 (en)
CH583874A5 (en)
CH586439A5 (en)
CH586871A5 (en)
CH589455A5 (en)
CH589897A5 (en)
CH590101A5 (en)
CH590160A5 (en)
CH590769A5 (en)
CH591109B5 (en)
CH591910A5 (en)
CH592031A5 (en)

Legal Events

Date Code Title Description
ST Notification of lapse